ANITA TULI-KENDALL: Open Payments
NPI 1285064170 · GAITHERSBURG, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,527 in 66 payments from 13 companies in 2025. Trend: 2023 $774 · 2024 $1,073 · 2025 $1,527
Food & beverage: $1,427Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $334 |
| Lilly USA, LLC | 8 | $214 |
| Indivior Inc. | 13 | $178 |
| ABBVIE INC. | 10 | $176 |
| Exact Sciences Corporation | 6 | $145 |
| Astellas Pharma US Inc | 2 | $132 |
| Axsome Therapeutics, Inc. | 4 | $110 |
| Braeburn Inc. | 4 | $99 |
| AstraZeneca Pharmaceuticals LP | 2 | $57 |
| Ionis Pharmaceuticals, Inc. | 1 | $28 |
Products named: SUBLOCADE, MOUNJARO, Wegovy, UBRELVY, BRIXADI, Saxenda, Cologuard Collection Kit, Ozempic.
Industry payments across MD — which companies pay providers there.
